RetinalGenix Technologies Inc.
RetinalGenix Technologies Inc.
Your view on RTGN
Overview
What the company does, where it operates, and who runs it.
About RetinalGenix Technologies Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Jerry Katzman
- Headquarters
- 1450 North Mcdowell Boulevard, Apollo Beach, CA, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Jerry Katzman
- Headquarters
- 1450 North Mcdowell Boulevard, Apollo Beach, CA, US
RetinalGeniX Technologies, Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ocular, optical, and sight-threatening disorders. Its products include the RetinalGeniX Imaging System, a diabetic non-mydriatic mass retinal imaging and screening device; and RetinalCam, a real-time in-home retinal monitoring, imaging, and physician alert system. The company was incorporated in 2017 and is headquartered in Petaluma, California. RetinalGenix Technologies Inc. is a subsidiary of Sanovas Ophthalmology, LLC.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.